Thiotepa
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Thiotepa |
| DrugBank ID | DB04572 |
| KG Predictions | 117 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 117 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| non-papillary transitional cell carcinoma of the bladder | KG |
| ovarian clear cell adenocarcinoma | KG |
| Hodgkins lymphoma | KG |
| non-Hodgkin lymphoma | KG |
| lymphosarcoma | KG |
| lymphoma | KG |
| hereditary breast ovarian cancer syndrome | KG |
| urinary bladder small cell neuroendocrine carcinoma | KG |
| primary non-gestational choriocarcinoma of ovary | KG |
| ovarian carcinosarcoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB04572
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.